ITUS Corporation Licenses CAR-T Technology from The Wistar Institute – PR Newswire (press release)
|
ITUS Corporation Licenses CAR–T Technology from The Wistar Institute
PR Newswire (press release) SAN JOSE, Calif., Nov. 14, 2017 /PRNewswire/ — ITUS Corporation (NASDAQ: ITUS) today announced that it has executed an exclusive worldwide license agreement with The Wistar Institute for a Chimeric Antigen Receptor T–Cell (CAR-T) technology aimed … Shares now up at $2.91 (ITUS) ITUS Corporation Licenses CAR–T… |
